Venlafaxine (Effexor)

Venlafaxine, commonly known by its brand name Effexor, is a prescription medication used to treat depression and anxiety disorders, making it an important tool in mental health management.

Research indicates that venlafaxine can effectively alleviate symptoms of depression such as anhedonia and amotivation. However, the drug also comes with potential side effects like hypoglycemia and urinary retention. Additionally, there have been reports linking venlafaxine to more serious conditions including rhabdomyolysis and renal impairment.

This medication is notably linked to renal impairment, a connection supported by evidence from observational studies. Another significant association involves the risk of urinary issues, which can affect quality of life for those taking the drug.

It's important to note that while these connections are established, more research is needed to fully understand the breadth and depth of venlafaxine’s effects and side effects.

Sources

• Neuropharmacology of venlafaxine. (PMID:11098411)
• Venlafaxine-induced hypoglycemia. (PMID:33875464)
• Venlafaxine-Induced Urinary Retention. (PMID:34000145)
• Venlafaxine-Associated Rhabdomyolysis: A Literature Review. (PMID:38506608)
• Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder. (PMID:38685594)
• Venlafaxine pharmacogenetics: a comprehensive review. (PMID:31368838)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._